Design and immunogenicity assessment of HIV-1 virus-like particles as a candidate vaccine (Q39427650)

11 September 2017

title

Design and immunogenicity assessment of HIV-1 virus-like particles as a candidate vaccine (English)

1 reference

11 September 2017

0 references

1 reference

XiZhen Zhang

1

1 reference

11 September 2017

XiaoDan Wang

2

1 reference

11 September 2017

DongHai Zhao

3

1 reference

11 September 2017

XiangYu Meng

4

1 reference

11 September 2017

XingHong Zhao

5

1 reference

11 September 2017

XiangHui Yu

6

1 reference

11 September 2017

Wei Kong

7

1 reference

11 September 2017

publication date

1 November 2011

1 reference

Science in China. Series C: Life Sciences

11 September 2017

published in

1 reference

11 September 2017

volume

54

1 reference

11 September 2017

issue

11

1 reference

11 September 2017

page(s)

1042-1047

1 reference

https://scigraph.springernature.com/pub.10.1007/s11427-011-4244-0

11 September 2017

exact match

0 references

cites work

Cell entry by enveloped viruses: redox considerations for HIV and SARS-coronavirus

1 reference

https://api.crossref.org/works/10.1007%2FS11427-011-4244-0

Antibodies to CD4-induced sites in HIV gp120 correlate with the control of SHIV challenge in macaques vaccinated with subunit immunogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-011-4244-0

HIV-1 membrane fusion: targets of opportunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-011-4244-0

The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-011-4244-0

Conformational HIV-1 envelope on particulate structures: a tool for chemokine coreceptor binding studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-011-4244-0

High efficient production of Pr55(gag) virus-like particles expressing multiple HIV-1 epitopes, including a gp120 protein derived from an Ugandan HIV-1 isolate of subtype A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-011-4244-0

Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-011-4244-0

Assembly of SIV virus-like particles containing envelope proteins using a baculovirus expression system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-011-4244-0

Incorporation of high levels of chimeric human immunodeficiency virus envelope glycoproteins into virus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-011-4244-0

A comparative immunogenicity study of HIV-1 virus-like particles bearing various forms of envelope proteins, particles bearing no envelope and soluble monomeric gp120.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-011-4244-0

Virus-like particle and DNA-based candidate AIDS vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-011-4244-0

Dendritic cells process exogenous viral proteins and virus-like particles for class I presentation to CD8+ cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-011-4244-0

Increased incorporation of chimeric human immunodeficiency virus type 1 gp120 proteins into Pr55gag virus-like particles by an Epstein-Barr virus gp220/350-derived transmembrane domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-011-4244-0

Alternative pathways for processing exogenous and endogenous antigens that can generate peptides for MHC class I-restricted presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-011-4244-0

Generation of HIV-1 Virus-Like Particles expressing different HIV-1 glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-011-4244-0

Human immunodeficiency virus type-1 (HIV-1) Pr55gag virus-like particles are potent activators of human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-011-4244-0

Recombinant HIV-1 Pr55gag virus-like particles: potent stimulators of innate and acquired immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-011-4244-0

Virus-like particles as HIV-1 vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-011-4244-0

Virus-like particles: designing an effective AIDS vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-011-4244-0

Vaccines against intracellular infections requiring cellular immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-011-4244-0

Studies on processing, particle formation, and immunogenicity of the HIV-1 gag gene product: a possible component of a HIV vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-011-4244-0

HIV type 1 Gag virus-like particle budding from spheroplasts of Saccharomyces cerevisiae

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-011-4244-0

Yeast-derived human immunodeficiency virus type 1 p55(gag) virus-like particles activate dendritic cells (DCs) and induce perforin expression in Gag-specific CD8(+) T cells by cross-presentation of DCs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-011-4244-0

[Design of virus-like particles, exposing HIV-1 epitopes]

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22173311

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Current progress in the development of a prophylactic vaccine for HIV-1.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22173311

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Assembly and extracellular release of chimeric HIV-1 Pr55gag retrovirus-like particles

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22173311

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11427-011-4244-0

1 reference

11 September 2017

1 reference